Gees don't be swayed by me.
But when you can get exposure to some really good assets at a 40% discount...
Like you identified though, the fee structure is absolutely disgraceful.
I have been following one of their investments, Imugene for a very long time. In the Australian biotech scene, they are at the forefront of cancer treatment.
How long can you possibly justify keeping a fund going when it's trading at nearly half its NAV???
Thoughts, page-12
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
